Cornils Kerstin, Lange Claudia, Schambach Axel, Brugman Martijn H, Nowak Regine, Lioznov Michael, Baum Christopher, Fehse Boris
Experimental Pediatric Oncology and Hematology, Pediatric Clinic III, University Hospital of the Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.
Mol Ther. 2009 Jan;17(1):131-43. doi: 10.1038/mt.2008.238. Epub 2008 Nov 11.
Stable genetic modification of stem cells holds great promise for gene therapy and marking, but commonly used gamma-retroviral vectors were found to influence growth/survival characteristics of hematopoietic stem cells (HSCs) by insertional mutagenesis. In this article, we show that promoter-deprived gamma-retroviral self-inactivating (pd-SIN) vectors allow stable genetic marking of serially reconstituting murine HSC. In contrast to findings with gamma-retroviral long terminal repeat (LTR) vectors, serial transplantation of pd-SIN-marked HSC in a sensitive mouse model was apparently not associated with induced clonal imbalance of gene-marked HSC. Furthermore, insertions of pd-SIN into protooncogenes, growth-promoting and signaling genes occurred significantly less frequent than in control experiments with LTR vectors. Also, transcriptional dysregulation of neighboring genes potentially caused by the pd-SIN insertion was rarely seen and comparatively weak. The integration pattern of promotor-deprived SIN vectors in reconstituting HSC seems to depend on the transcriptional activity of the respective gene loci reflecting the picture described for LTR vectors. In conclusion, our data strongly support the use of SIN vectors for gene-marking studies and suggest an increased therapeutic index for vectors lacking enhancers active in HSC.
干细胞的稳定基因改造在基因治疗和标记方面具有巨大潜力,但人们发现常用的γ-逆转录病毒载体通过插入诱变影响造血干细胞(HSC)的生长/存活特性。在本文中,我们表明启动子缺失的γ-逆转录病毒自失活(pd-SIN)载体能够对连续重建的小鼠造血干细胞进行稳定的基因标记。与γ-逆转录病毒长末端重复序列(LTR)载体的研究结果相反,在一个敏感小鼠模型中对pd-SIN标记的造血干细胞进行连续移植,显然与基因标记的造血干细胞诱导的克隆失衡无关。此外,与LTR载体的对照实验相比,pd-SIN插入原癌基因、生长促进基因和信号基因的频率显著降低。而且,由pd-SIN插入可能导致的邻近基因的转录失调很少见且相对较弱。启动子缺失的SIN载体在重建造血干细胞中的整合模式似乎取决于各个基因位点的转录活性,这与LTR载体所描述的情况相符。总之,我们的数据有力地支持了使用SIN载体进行基因标记研究,并表明对于缺乏在造血干细胞中具有活性的增强子的载体,其治疗指数有所提高。